Ezequiel Renzulli: I am excited to announce the launch of Rio Sur Advisory Partners
Ezequiel Renzulli, Chief Executive Officer at Rio Sur Advisory Partners, shared on LinkedIn:
“After six incredible years at Tempus AI, serving in various roles, I am thrilled to announce that I am embarking on a new journey to fulfill a long-time goal of mine.
First and foremost, I want to extend my heartfelt gratitude to the entire Tempus family. Your support and camaraderie have meant the world to me, and I wish Tempus continued success.
The mission, talent, and unified goal have remained clear and consistent since the day I joined, and I will dearly miss working with my friends and colleagues daily.
After 15+ years of dedication to my employers, serving in diverse leadership roles, and contributing to the creation and implementation of successful commercial strategies with both Health Institutions and Life Science companies, I am now ready to follow my own mission.
With the help of friends, colleagues, and family, I am excited to announce the launch of Rio Sur Advisory Partners.
The firm will focus on helping Health Systems, Health Tech Companies, Life Science and BioPharma, and Venture Capital firms explore innovative and strategic approaches to collaboration.
We aim to streamline decision-making processes and assist with the implementation of solutions, with a niche focus in Oncology.
Starting next week, we’ll embark on exciting projects with key clients, aiming to transform and expand the utility of data across various domains, along with other impactful initiatives.
Additionally, I am excited to announce that I will be taking on an Advisory role and a Chief Strategy Officer position with a leading Precision Medicine company that has roots in LATAM, an extensive global reach, and ambitious plans for expansion.
Stay tuned for more details on this significant development.
Exciting times are ahead, and I feel prepared and enthusiastic about this new chapter. Thank you to everyone who has wished me success; your support is deeply appreciated.”
Source: Ezequiel Renzulli/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023